Novartis launches Jakavi in 50+ countries; J&J to market hep C drug in Europe;

> Novartis ($NVS) has launched myelofibrosis drug Jakavi in Singapore and 50 other countries. Report

> Johnson & Johnson's ($JNJ) Janssen has won EU marketing authorization for hep C drug Olysio. Release

> Tolmar Pharma has regained marketing rights for prostate cancer drug Eligard in the U.S. and Puerto Rico. More

> A new report highlights the meningococcal vaccines market through 2019. Release

And Finally... Some tech companies are betting that sifting through patients' social media posts will yield critical side-effect insights that drugmakers will buy. More